Search by Drug Name or NDC

    NDC 69097-0853-07 naproxen 250 mg/1 Details

    naproxen 250 mg/1

    naproxen is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is NAPROXEN.

    Product Information

    NDC 69097-0853
    Product ID 69097-853_598c64ad-f0c4-495e-b2c2-cde215d2572d
    Associated GPIs 66100060000305
    GCN Sequence Number 008360
    GCN Sequence Number Description naproxen TABLET 250 MG ORAL
    HIC3 S2B
    HIC3 Description NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS
    GCN 35790
    HICL Sequence Number 003727
    HICL Sequence Number Description NAPROXEN
    Brand/Generic Generic
    Proprietary Name naproxen
    Proprietary Name Suffix n/a
    Non-Proprietary Name naproxen
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name NAPROXEN
    Labeler Name Cipla USA Inc.
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091305
    Listing Certified Through 2024-12-31

    Package

    NDC 69097-0853-07 (69097085307)

    NDC Package Code 69097-853-07
    Billing NDC 69097085307
    Package 100 TABLET in 1 BOTTLE (69097-853-07)
    Marketing Start Date 2016-07-05
    NDC Exclude Flag N
    Pricing Information N/A